Peptide Aβ(16-25) Forms Nanofilms in the Process of Its Aggregation

Area of Science:

• Biochemistry
• Biophysics
• Materials Science

Background:

• Amyloidogenic peptides, such as Aβ(1-42), are implicated in neurodegenerative diseases.
• Understanding the aggregation mechanisms of peptide fragments is crucial for developing therapeutic strategies.
• The Aβ(16-25) fragment was specifically chosen for its predicted amyloidogenic properties.

Purpose of the Study:

• To develop a method for the synthesis and high purification of the Aβ(16-25) peptide fragment.
• To investigate the aggregation process and structural characteristics of the synthesized Aβ(16-25) fragment.
• To evaluate the potential of Aβ(16-25) as a model for amyloid fibril formation and as a nanomaterial.

Main Methods:

• Peptide synthesis and high-purification techniques.
• Electron microscopy (EM) for morphological analysis.
• X-ray diffraction (XRD) analysis for structural characterization.

Main Results:

• Successful synthesis and high purification of the Aβ(16-25) peptide fragment.
• Electron microscopy revealed the formation of a film, not typical amyloid fibrils.
• X-ray diffraction data showed two main reflections (4.6-4.8 Å and 8-12 Å), characteristic of cross-β structures found in amyloid fibrils.

Conclusions:

• The Aβ(16-25) fragment exhibits structural features indicative of amyloid formation, despite differing morphology.
• This peptide fragment is a promising candidate for studying peptide/protein polymerization.
• Aβ(16-25) holds potential as a nanomaterial for investigating various biological processes.